DONNA MAYER: Open Payments
NPI 1932118635 · NEW LEXINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 57 payments from 14 companies in 2025. Trend: 2023 $1,335 · 2024 $1,056 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $176 |
| Novo Nordisk Inc | 10 | $154 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $95 |
| PFIZER INC. | 4 | $74 |
| ABBVIE INC. | 4 | $65 |
| Dexcom, Inc. | 3 | $64 |
| Lilly USA, LLC | 4 | $58 |
| Aimmune Therapeutics, Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $38 |
Products named: TRELEGY ELLIPTA, Ozempic, CAPLYTA, Dexcom G6 Transmitter, MOUNJARO, NURTEC ODT, AIRSUPRA, ZENPEP.
Industry payments across OH — which companies pay providers there.
